• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测急诊过敏反应患者重复肾上腺素给药的因素。

Predictors of Repeat Epinephrine Administration for Emergency Department Patients with Anaphylaxis.

机构信息

Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.

Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.

出版信息

J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):576-84. doi: 10.1016/j.jaip.2015.04.009. Epub 2015 May 29.

DOI:10.1016/j.jaip.2015.04.009
PMID:26032476
Abstract

BACKGROUND

Risk factors that predict which patients with anaphylaxis might require repeat doses of epinephrine are poorly understood.

OBJECTIVE

The objective of this study was to identify risk factors associated with the need for multiple doses of epinephrine during an anaphylactic reaction.

METHODS

Patients were included if they met diagnostic criteria for anaphylaxis on presentation to the emergency department (ED) at our academic medical center between April 2008 and February 2014. Data were collected on allergic history, presenting signs and symptoms, anaphylaxis management, and disposition. Univariable and multivariable analyses were performed to estimate associations between possible risk factors and the need for multiple doses.

RESULTS

Of 582 ED patients with anaphylaxis, 45 (8%) required multiple doses of epinephrine. By multivariable analysis, factors associated with the need for repeat doses were a history of anaphylaxis (odds ratio [OR], 2.5 [95% CI, 1.3-4.7]; P = .005), the presence of flushing or diaphoresis (OR, 2.4 [95% CI, 1.3-4.5]; P = .007), and the presence of dyspnea (OR, 2.2 [95% CI, 1.0-5.0]; P = .046). Patients who received more than 1 dose were more likely to be admitted to the general medical floor (OR, 2.8 [95% CI, 1.1-7.2]; P = .03) or intensive care unit (OR, 7.6 [95% CI, 3.7-15.6]; P < .001).

CONCLUSION

Patients with a history of anaphylaxis, flushing or diaphoresis, or dyspnea may require multiple doses of epinephrine to treat anaphylactic reactions. Patients who require more than 1 dose are more likely to be admitted to the hospital, thus increasing health care resource utilization.

摘要

背景

预测哪些过敏反应患者可能需要重复使用肾上腺素的风险因素尚未得到很好的理解。

目的

本研究的目的是确定与过敏反应期间需要多次使用肾上腺素相关的风险因素。

方法

如果患者在 2008 年 4 月至 2014 年 2 月期间在我们的学术医疗中心的急诊部就诊时符合过敏反应的诊断标准,则将其纳入研究。收集过敏史、就诊时的症状和体征、过敏反应的管理以及转归等数据。进行单变量和多变量分析,以评估可能的风险因素与需要多次使用肾上腺素之间的关联。

结果

在 582 例过敏反应的 ED 患者中,有 45 例(8%)需要多次使用肾上腺素。通过多变量分析,与需要重复剂量相关的因素是过敏反应史(比值比[OR],2.5[95%CI,1.3-4.7];P=.005)、潮红或出汗(OR,2.4[95%CI,1.3-4.5];P=.007)和呼吸困难(OR,2.2[95%CI,1.0-5.0];P=.046)。接受超过 1 剂的患者更有可能被收治到普通医疗病房(OR,2.8[95%CI,1.1-7.2];P=.03)或重症监护病房(OR,7.6[95%CI,3.7-15.6];P<.001)。

结论

有过敏反应史、潮红或出汗或呼吸困难的患者可能需要多次使用肾上腺素来治疗过敏反应。需要超过 1 剂的患者更有可能住院,从而增加医疗资源的利用。

相似文献

1
Predictors of Repeat Epinephrine Administration for Emergency Department Patients with Anaphylaxis.预测急诊过敏反应患者重复肾上腺素给药的因素。
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):576-84. doi: 10.1016/j.jaip.2015.04.009. Epub 2015 May 29.
2
Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine.肾上腺素在过敏反应中的应用:与肌内注射肾上腺素相比,静脉推注肾上腺素后发生心血管并发症和用药过量的风险更高。
J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):76-80. doi: 10.1016/j.jaip.2014.06.007. Epub 2014 Aug 29.
3
Repeat epinephrine treatments for food-related allergic reactions that present to the emergency department.对因食物过敏而到急诊科就诊的患者,应重复使用肾上腺素治疗。
Allergy Asthma Proc. 2010 Jul-Aug;31(4):308-16. doi: 10.2500/aap.2010.31.3375.
4
Food-induced anaphylaxis and repeated epinephrine treatments.食物诱发的过敏反应及反复使用肾上腺素治疗
Ann Allergy Asthma Immunol. 2007 Nov;99(5):429-32. doi: 10.1016/S1081-1206(10)60568-6.
5
Patients Taking β-Blockers Do Not Require Increased Doses of Epinephrine for Anaphylaxis.β受体阻滞剂使用者在发生过敏反应时无需增加肾上腺素剂量。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1553-1558.e1. doi: 10.1016/j.jaip.2017.12.020. Epub 2018 Feb 13.
6
Anaphylaxis management in the pediatric emergency department: opportunities for improvement.儿科急诊科的过敏反应管理:改进的机会
Pediatr Emerg Care. 2010 Feb;26(2):71-6. doi: 10.1097/PEC.0b013e3181ce2e1c.
7
Predictors of biphasic reactions in the emergency department for patients with anaphylaxis.预测急诊过敏反应患者出现双相反应的因素。
J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):281-7. doi: 10.1016/j.jaip.2014.01.012. Epub 2014 Apr 2.
8
Further Evaluation of Factors That May Predict Biphasic Reactions in Emergency Department Anaphylaxis Patients.进一步评估可能预测急诊科过敏反应患者双相反应的因素。
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1295-1301. doi: 10.1016/j.jaip.2017.07.020.
9
Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis.过敏反应儿童双相反应的流行病学及临床预测因素
Ann Allergy Asthma Immunol. 2015 Sep;115(3):217-223.e2. doi: 10.1016/j.anai.2015.05.013. Epub 2015 Jun 22.
10
Epinephrine use and outcomes in anaphylaxis patients transported by emergency medical services.由紧急医疗服务转运的过敏反应患者使用肾上腺素的情况及预后
Am J Emerg Med. 2014 Sep;32(9):1097-102. doi: 10.1016/j.ajem.2014.05.014. Epub 2014 May 20.

引用本文的文献

1
Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study.重复使用肾上腺素以确定儿童过敏反应观察期的时机:一项回顾性队列研究。
Lancet Child Adolesc Health. 2025 Jul;9(7):484-496. doi: 10.1016/S2352-4642(25)00139-7.
2
Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review.用于食物过敏的变应原特异性免疫疗法中的益生菌及其他佐剂:一项全面综述
Front Allergy. 2024 Oct 10;5:1473352. doi: 10.3389/falgy.2024.1473352. eCollection 2024.
3
IgE-mediated cow's milk allergy in Brazilian children: Outcomes of oral food challenge.
巴西儿童中IgE介导的牛奶过敏:口服食物激发试验的结果
World Allergy Organ J. 2023 May 20;16(5):100781. doi: 10.1016/j.waojou.2023.100781. eCollection 2023 May.
4
Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis.难治性过敏反应:严重过敏反应的一种新实体。
J Allergy Clin Immunol Pract. 2023 Jul;11(7):2043-2048. doi: 10.1016/j.jaip.2023.04.037. Epub 2023 May 10.
5
Trends and Variation in Pediatric Anaphylaxis Care From 2016 to 2022.2016 年至 2022 年儿科过敏反应护理的趋势和变化。
J Allergy Clin Immunol Pract. 2023 Apr;11(4):1184-1189. doi: 10.1016/j.jaip.2023.01.029. Epub 2023 Feb 1.
6
A guide for the management of post vaccination allergy and anaphylaxis in a pharmacy clinic.药房诊所接种疫苗后过敏和过敏反应管理指南。
Health SA. 2022 Nov 15;27:1987. doi: 10.4102/hsag.v27i0.1987. eCollection 2022.
7
Canadian Anaphylaxis Network-Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): a prospective, cohort study protocol.加拿大过敏反应网络-预测急诊过敏反应后复发(CAN-PREPARE):一项前瞻性队列研究方案。
BMJ Open. 2022 Oct 31;12(10):e061976. doi: 10.1136/bmjopen-2022-061976.
8
A case report: anaphylaxis to cefazolin during renal transplant surgery.病例报告:肾移植手术期间对头孢唑林过敏反应
Allergy Asthma Clin Immunol. 2021 May 29;17(1):54. doi: 10.1186/s13223-021-00559-w.
9
Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis.在过敏反应中使用多种肾上腺素剂量:系统评价和荟萃分析。
J Allergy Clin Immunol. 2021 Nov;148(5):1307-1315. doi: 10.1016/j.jaci.2021.03.042. Epub 2021 Apr 20.
10
Second Dose of Epinephrine for Anaphylaxis in the First Aid Setting: A Scoping Review.急救场景中用于过敏反应的第二剂肾上腺素:一项范围综述
Cureus. 2020 Nov 9;12(11):e11401. doi: 10.7759/cureus.11401.